Clinical Trial Update: Therapeutic Vaccine in Patients With Human Papillomavirus HPV-positive Oropharyngeal Cancer [Phase 1, Phase 2]

View source ↗

Summary

An investigational therapeutic vaccine for HPV-positive oropharyngeal cancer is in a Phase 1/2 trial and currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer
• Oropharyngeal Cancer

Drugs mentioned

• Investigational therapeutic vaccine for HPV-positive oropharyngeal cancer

Snippet

Sponsor: Gustave Roussy, Cancer Campus, Grand Paris | Conditions: Head and Neck Carcinoma, Adult Disease | Phase 1, Phase 2 | Status: RECRUITING